Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.

H, Al-Samkari; S, Gupta; RK, Leaf; W, Wang; RP, Rosovsky; SK, Brenner; SS, Hayek; H, Berlin; R, Kapoor; S, Shaefi; ML, Melamed; A, Sutherland; J, Radbel; A, Green; BT, Garibaldi; A, Srivastava; A, Leonberg-Yoo; AM, Shehata; JE, Flythe; A, Rashidi; N, Goyal; L, Chan; KS, Mathews; SS, Hedayati; R, Dy; SM, Toth-Manikowski; J, Zhang; M, Mallappallil; RE, Redfern; AD, Bansal; SAP, Short; MG, Vangel; AJ, Admon; MW, Semler; KA, Bauer; MA, Hernán; DE, Leaf

doi:10.7326/m20-6739

Public

Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.

Shared by NobleBlocks on Jan 26, 2021 • 12:00 AM UTC

Authors:

Al-Samkari H

Gupta S

Leaf RK

Abstract

Background Hypercoagulability may be a key mechanism of death in patients with coronavirus disease 2019 (COVID-19).Objective To evaluate the incidence of venous thromboembolism (VTE) and major bleeding in critically ill patients with COVID-19 and examine the observational effect of early therapeutic...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!